COMMUNIQUÉS West-GlobeNewswire

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
05/11/2025
NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on November 1, 2025, the [...]
Praxis Precision Medicines to Participate in Upcoming Investor Conferences
05/11/2025
BOSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous [...]
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results
05/11/2025
Claseprubart achieved statistically significant and clinically meaningful improvements in Myasthenia Gravis Activities of Daily Living (MG-ADL), Quantitative Myasthenia Gravis (QMG), and other efficacy measures at Week [...]
FDA Warns Companies Over Illegal Marketing of Botox and Related Products
05/11/2025
Silver Spring, Md., Nov. 05, 2025 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration issued 18 warning letters to owners of websites illegally marketing unapproved and misbranded botulinum toxin products, [...]
Emerald Heights Social Accountability Committee Donates $305,000 to Support 15 Charities Benefiting Local Communities
05/11/2025
REDMOND, Wash., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Emerald Heights, a leading nonprofit senior living community, proudly announces a donation of $305,000 to 15 local charities through its Social Accountability Committee [...]
Genmab to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference in London
05/11/2025
Media Release COPENHAGEN, Denmark; November 5, 2025 Genmab A/S (Nasdaq: GMAB ) announced today that its Chief Executive Officer Jan Van de Winkel and C hief F inancial O fficer Anthony Pagano will participate in a [...]
UPDATE - MMI Receives IDE Approval from FDA for First Robotic Microsurgical Study in Alzheimer’s Patients
05/11/2025
First-of-its-kind study represents the potential for robotic-enabled microsurgical intervention for neurodegenerative diseases, including Alzheimer’s JACKSONVILLE, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) -- MMI (Medical [...]
VALNEVA Déclaration d’actions et de droits de vote : 31 octobre 2025
05/11/2025
VALNEVA Déclaration d’actions et de droits de vote 31 octobre 2025 __________________________________________________________________________________________ Dénomination sociale : VALNEVA Adresse du siège social : 6 [...]
VALNEVA Declaration of shares and voting rights: October 31, 2025
05/11/2025
VALNEVA Declaration of shares and voting rights October 31, 2025 __________________________________________________________________________________________ Company name: VALNEVA Registered office: 6 rue Alain Bombard, [...]
beyond|AESTHETICS Celebrates 10 Years of Excellence with Grand Holiday Event
05/11/2025
Camarillo, CA, Nov. 05, 2025 (GLOBE NEWSWIRE) -- beyond|AESTHETICS , a leader in the aesthetics industry, is thrilled to announce its 10 Year Anniversary Holiday Event, a spectacular celebration marking a decade of [...]
Idorsia to present new aprocitentan insights at ASN Kidney Week & AHA Scientific Sessions
05/11/2025
New analysis confirms reductions in blood pressure and albuminuria by aprocitentan in patients with true resistant hypertension and high cardiovascular risk – including chronic kidney disease Allschwil, Switzerland – [...]
FORM 8.1(a) & (b) - Avadel Pharmaceuticals plc
05/11/2025
U.K. DISCLOSURE, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Ap9 FORM 8.1(a) & (b) (Opening Position Disclosure) IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE UNDER RULE 8.1(a) AND (b) OF THE IRISH TAKEOVER PANEL ACT, 1997 [...]
SeaStar Medical to Report Third Quarter Financial Results on November 13, 2025
05/11/2025
DENVER, Nov. 05, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and [...]
MMI Receives IDE Approval from FDA for First Robotic Microsurgical Study in Alzheimer’s Patients
05/11/2025
First-of-its-kind study represents the potential for robotic-enabled microsurgical intervention for neurodegenerative diseases, including Alzheimer’s JACKSONVILLE, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) -- MMI (Medical [...]
Ambio Life Sciences Launches Europe’s First Physician-Led Ibogaine Clinic
05/11/2025
With the opening of its new clinic on Malta’s scenic Mellieha Bay, Ambio becomes the only transcontinental ibogaine provider in the world The clinic responds to high global demand for safe ibogaine treatment with added [...]
Mucinex Brings Mr. Mucus to Canada for the First Time With Proven 12-Hour Cold and Flu Relief
05/11/2025
The germ-loving, cult-favourite Mucinex mascot Mr. Mucus makes his Canadian debut in a coast-to-coast campaign challenging Canadians to kick this seasonal nuisance to the curb TORONTO, Nov. 05, 2025 (GLOBE NEWSWIRE) -- [...]
Processa Pharmaceuticals Announces Poster Presentation of Adaptive Phase 2/3 PCS499 Study in FSGS at ASN Kidney Week 2025
05/11/2025
VERO BEACH, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company developing Next Generation Cancer (NGC) therapies and innovative treatments [...]
MiNK Therapeutics to Report Third Quarter 2025 Financial Results and Highlight Clinical and Corporate Milestones Advancing iNKT Platform Toward Pivotal Development
05/11/2025
NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics , Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and [...]
HiFi Solves Consortium Publishes First Major Study Demonstrating the Clinical Research Power of PacBio HiFi Genomes
05/11/2025
New multi-center study identifies 100% of clinically relevant variants in the study, including those not detected by short-read sequencing technologies, positioning HiFi as the bridge between research and clinical-grade [...]

Pages